Here’s Why Agilent (A) Traded Down in Q1
Madison Investments, an investment advisor, released its “Madison Sustainable Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Agilent Technologies Inc. (A)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Generation Investment Management David Blood And Al Gore | 5,775,860 | $681,609,241 | +16% | 4.33% |
| 2. | Cantillon Capital Management William Von Mueffling | 3,126,283 | $368,932,656 | -3% | 2.13% |
| 3. | Impax Asset Management Ian Simm | 3,022,842 | $356,725,642 | +4% | 2.05% |
| 4. | AQR Capital Management Cliff Asness | 2,041,826 | $240,955,943 | +425% | 0.2% |
| 5. | Citadel Investment Group Ken Griffin | 1,647,899 | $194,468,561 | -22% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | $0.00 | 24,219 | 2023-09-28 | Filing | |
| $111.09 | 3 | $287.72 | 24,222 | 2023-09-28 | Filing | |
| $37.08 | 600 | $22,248.00 | 46,823 | 2012-08-28 | Filing | |
| $37.28 | 1,155 | $43,058.40 | 46,223 | 2012-08-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $113.45 | 2,000 | $226,900.00 | 35,448 | 2025-08-01 | Filing | |
| $117.44 | 1,508 | $177,099.52 | 37,448 | 2025-07-01 | Filing | |
| $116.53 | 8 | $904.30 | 1,677 | 2025-06-18 | Filing | |
| $116.46 | 1,819 | $211,844.38 | 35,737 | 2025-03-31 | Filing | |
| $121.98 | 1,908 | $232,691.32 | 21,786 | 2025-03-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 33,997,845 | $4,012,085,688 | 0.06% | |
| 2. | 25,891,382 | $3,055,441,996 | 0.06% | |
| 3. | 13,227,387 | $1,560,963,941 | 0.5% | |
| 4. | 12,453,528 | $1,469,640,839 | 0.06% | |
| 5. | 8,947,179 | $1,055,856,593 | 0.19% |
News See All
Jim Cramer Says "Agilent Technologies (A) Is Really Interesting Now”
We recently published a list of Jim Cramer Recently Discussed These 15 Stocks. In this article, we are going to take a look at where Agilent Technologies, Inc.
Jim Cramer Recently Discussed These 15 Stocks
During the most recent episode of Mad Money, Jim Cramer shared his thoughts on several key events, including a wave of upcoming Q1 2025 earnings and, more critically, Friday’s all-important payroll ...
Stifel Nicolaus Maintains Buy Rating on Agilent Technologies (A), Sets $151 PT
On May 29, Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Agilent Technologies, Inc. (NYSE:A) and set a price target of $151.00.
BofA Maintains Hold Rating on Agilent Technologies (A) After Q2 Report
On May 29, analyst Michael Ryskin from Bank of America Securities reiterated a Hold rating on Agilent Technologies Inc (NYSE:A) with a $128.00 price target.
Here’s Why Agilent Technologies (A) Traded Lower in Q1
Impax Asset Management, an investment management company, released its “Impax Global Environmental Markets Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Generation Investment Management’s Investment Thesis for Agilent Technologies (A)
Generation Investment Management, an investment management firm, released its “Global Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Agilent Technologies, Inc. (NYSE:A) Q2 2025 Earnings Call Transcript
Operator: Good afternoon. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Second Quarter 2025 Agilent Technologies Inc.
Best Retirement Portfolio for a 65-Year-Old
The American retirement system is feeling the strain, with challenges like shrinking fees, underfunded plans, and an aging population slowing down industry growth.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.